• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆蛋白质组学分析用于阿尔茨海默病诊断的潜在生物标志物。

Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease.

机构信息

Department of Environmental and Occupational Health, National Cheng Kung University, Tainan, Taiwan.

出版信息

Proteomics Clin Appl. 2007 May;1(5):506-12. doi: 10.1002/prca.200600684. Epub 2007 Apr 19.

DOI:10.1002/prca.200600684
PMID:21136702
Abstract

The objective of this study was to search for biological markers associated with Alzheimer's disease (AD). Plasma specimens obtained from ten pathologically diagnosed AD patients and ten non-demented (ND) control subjects were analyzed by a combination of 2-DE and MS. This strategy allowed us to identify six plasma proteins (alpha-1-antitrypsin, vitamin D-binding protein, inter-alpha-trypsin inhibitor family heavy chain-related protein, apolipoprotein J precursor, cAMP-dependent protein kinase catalytic subunit alpha 1, and an orf) whose 2-DE spot densities were different between the AD and ND groups. Due to their involvements in AD amyloid plaque formation, the plasma concentrations of alpha-1-antitrypsin and apolipoprotein J were further validated using either ELISA or Western blot. The results revealed that the plasma levels of alpha-1-antitrypsin in AD were higher than those of controls, confirming the 2-DE findings. However, no difference in total apolipoprotein J concentration was observed between the AD and ND groups. Considering the difference in resolving power to differentially quantitate protein isoforms provided by 2-DE and Western blot, 2-DE analysis combined with MS protein identification offers distinctive advantages when a disease-related protein isoform-specific variance is investigated.

摘要

本研究旨在寻找与阿尔茨海默病(AD)相关的生物标志物。通过二维电泳(2-DE)和质谱(MS)联用分析了 10 例经病理诊断的 AD 患者和 10 例非痴呆(ND)对照者的血浆标本。该策略使我们能够鉴定出 6 种血浆蛋白(α-1-抗胰蛋白酶、维生素 D 结合蛋白、α-胰蛋白酶抑制剂重链相关蛋白家族、载脂蛋白 J 前体、cAMP 依赖性蛋白激酶催化亚单位α1 和一个 ORF),其在 AD 和 ND 组之间的 2-DE 点密度不同。由于它们参与 AD 淀粉样斑块形成,因此使用 ELISA 或 Western blot 进一步验证了 α-1-抗胰蛋白酶和载脂蛋白 J 的血浆浓度。结果表明,AD 患者的血浆α-1-抗胰蛋白酶水平高于对照组,证实了 2-DE 的发现。然而,AD 和 ND 组之间总载脂蛋白 J 浓度没有差异。考虑到 2-DE 和 Western blot 在定量分析蛋白异构体方面的分辨率差异,当研究与疾病相关的蛋白异构体特异性差异时,2-DE 分析结合 MS 蛋白鉴定具有独特的优势。

相似文献

1
Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease.血浆蛋白质组学分析用于阿尔茨海默病诊断的潜在生物标志物。
Proteomics Clin Appl. 2007 May;1(5):506-12. doi: 10.1002/prca.200600684. Epub 2007 Apr 19.
2
Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.用于轻度认知障碍和阿尔茨海默病的血浆生物标志物。
Brain Res Rev. 2009 Oct;61(2):69-80. doi: 10.1016/j.brainresrev.2009.05.003. Epub 2009 May 21.
3
Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.脑脊液中的神经元五聚体受体作为神经退行性疾病的潜在生物标志物。
Brain Res. 2009 Apr 10;1265:158-70. doi: 10.1016/j.brainres.2009.01.058. Epub 2009 Feb 6.
4
Identification of oxidized plasma proteins in Alzheimer's disease.
Biochem Biophys Res Commun. 2002 May 24;293(5):1566-70. doi: 10.1016/S0006-291X(02)00420-5.
5
Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.泰国诗里拉吉医院对阿尔茨海默病(AD)及其他痴呆症患者的脑脊液(CSF)β-淀粉样蛋白(1-42)、磷酸化tau蛋白(ptau-181)和总tau蛋白进行评估。
J Med Assoc Thai. 2011 Feb;94 Suppl 1:S77-83.
6
Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.脑脊液中异常磷酸化的tau蛋白和β淀粉样蛋白片段与轻度认知障碍(MCI)受试者的认知障碍相关。
Neurobiol Aging. 2006 Feb;27(2):237-44. doi: 10.1016/j.neurobiolaging.2005.01.011. Epub 2005 Apr 7.
7
Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.血浆凝溶胶蛋白降低,并与阿尔茨海默病的衰退速度相关。
J Alzheimers Dis. 2010;21(2):585-96. doi: 10.3233/JAD-2010-100279.
8
Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease.联合血浆生物标志物和临床数据检测散发性阿尔茨海默病。
Neurosci Lett. 2012 May 16;516(2):232-6. doi: 10.1016/j.neulet.2012.03.094. Epub 2012 Apr 7.
9
Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease.阿尔茨海默病中载脂蛋白A-I降低的蛋白质组学鉴定
Dement Geriatr Cogn Disord. 2006;21(3):155-61. doi: 10.1159/000090676. Epub 2006 Jan 2.
10
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.通过免疫亲和纯化和稳定同位素稀释液相色谱/负电喷雾电离串联质谱法对阿尔茨海默病患者脑脊液中β淀粉样肽进行定量分析。
Rapid Commun Mass Spectrom. 2006;20(24):3723-35. doi: 10.1002/rcm.2787.

引用本文的文献

1
Vitamin D binding protein in psychiatric and neurological disorders: Implications for diagnosis and treatment.精神和神经疾病中的维生素D结合蛋白:对诊断和治疗的意义
Genes Dis. 2024 Apr 15;11(5):101309. doi: 10.1016/j.gendis.2024.101309. eCollection 2024 Sep.
2
Analysis of plasma proteins using 2D gels and novel fluorescent probes: in search of blood based biomarkers for Alzheimer's disease.使用二维凝胶和新型荧光探针分析血浆蛋白质:寻找阿尔茨海默病的血液生物标志物。
Proteome Sci. 2022 Jan 26;20(1):2. doi: 10.1186/s12953-021-00185-9.
3
Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology.
淀粉样斑块的细胞外蛋白成分及其在阿尔茨海默病病理中的作用。
Mol Neurodegener. 2021 Aug 28;16(1):59. doi: 10.1186/s13024-021-00465-0.
4
Exosomal Aβ-Binding Proteins Identified by "In Silico" Analysis Represent Putative Blood-Derived Biomarker Candidates for Alzheimer´s Disease.通过“计算机分析”鉴定的外泌体 Aβ 结合蛋白代表阿尔茨海默病潜在的血源性生物标志物候选物。
Int J Mol Sci. 2021 Apr 11;22(8):3933. doi: 10.3390/ijms22083933.
5
Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.为什么在血浆阿尔茨海默病生物标志物的发现中需要考虑包容性。
J Alzheimers Dis. 2021;79(3):1327-1344. doi: 10.3233/JAD-201318.
6
Isoelectric point region pI≈7.4 as a treasure island of abnormal proteoforms in blood.等电点区域pI≈7.4作为血液中异常蛋白质变体的“宝岛”。
Discoveries (Craiova). 2016 Dec 1;4(4):e67. doi: 10.15190/d.2016.14.
7
Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental Validation.通过计算预测和实验验证识别阿尔茨海默病的血液生物标志物
Front Neurol. 2019 Jan 8;9:1158. doi: 10.3389/fneur.2018.01158. eCollection 2018.
8
Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.外周生物标志物在阿尔茨海默病和帕金森病的早期检测中的应用。
Mol Neurobiol. 2019 Mar;56(3):2256-2277. doi: 10.1007/s12035-018-1151-4. Epub 2018 Jul 14.
9
Low-Frequency Pulsed Electromagnetic Field Is Able to Modulate miRNAs in an Experimental Cell Model of Alzheimer's Disease.低频脉冲电磁场能够调节阿尔茨海默病实验细胞模型中的 miRNAs。
J Healthc Eng. 2017;2017:2530270. doi: 10.1155/2017/2530270. Epub 2017 May 2.
10
Alzheimer's disease: are blood and brain markers related? A systematic review.阿尔茨海默病:血液和大脑标志物相关吗?系统综述。
Ann Clin Transl Neurol. 2016 May 11;3(6):455-62. doi: 10.1002/acn3.313. eCollection 2016 Jun.